Abstract
No public abstract is available from the verified source records.
Marjolein Metselaar-Albers, Lourens Bloem, Dorieke van Balen, Karijn Suijkerbuijk, Arief Lalmohamed
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial
10.1016/s1470-2045(26)00191-9 · 2026
Association between proton pump inhibitor use and upper gastrointestinal cancer: a matched case-control study accounting for reverse causation and confounding by indication
10.1371/journal.pmed.1004842 · 2026
Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer
10.1016/j.annonc.2019.10.003 · 2020
No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC
10.1136/jitc-2023-008269 · 2024
No additional external references are available.